LncRNA nuclear-enriched abundant transcript 1 (NEAT1) was downregulated in CML patient samples, and inhibition of NEAT1 promoted imatinib-induced apoptosis [24]. This evidence concerns the gene NEAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.